Chemotherapy‐induced release of ADAM17 bearing EV as a potential resistance mechanism in ovarian cancer
Authors:
Open Access
- 5 July 2023
- journal article
- research article
- Published by Wiley in Journal of Extracellular Vesicles
- Vol. 12 (7) , e12338
Abstract
Ovarian cancer (OvCa) is the gynaecological disorder with the poorest prognosis due to the fast development of chemoresistance. We sought to connect chemoresistance and cancer cell‐derived extracellular vesicles (EV). The mechanisms of how chemoresistance is sustained by EV remained elusive. One potentially contributing factor is A Disintegrin and Metalloprotease 17 (ADAM17)—itself being able to promote chemoresistance and inducing tumour cell proliferation and survival via the Epidermal Growth Factor Receptor (EGFR) pathway by shedding several of its ligands including Amphiregulin (AREG). We now demonstrate that upon chemotherapeutic treatment, proteolytically active ADAM17 is released in association with EV from OvCa cells. In terms of function, we show that patient‐derived EV induce AREG shedding and restore chemoresistance in ADAM17‐deficient cells. Confirming that ADAM17‐containing EV transmit chemoresistance in OvCa, we propose that ADAM17 levels (also on EV) might serve as an indicator for tumour progression and the chemosensitivity status of a given patient.Keywords
This publication has 123 references indexed in Scilit:
- A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial ImmunityScience, 2012
- MicroRNAs are exported from malignant cells in customized particlesNucleic Acids Research, 2012
- Anticancer Drugs Cause Release of Exosomes with Heat Shock Proteins from Human Hepatocellular Carcinoma Cells That Elicit Effective Natural Killer Cell Antitumor Responses in VitroJournal of Biological Chemistry, 2012
- A Disintegrin and Metalloenzyme (ADAM) 17 Activation Is Regulated by α5β1 Integrin in Kidney Mesangial CellsPLOS ONE, 2012
- Amphiregulin Exosomes Increase Cancer Cell InvasionCurrent Biology, 2011
- Species Specificity of ADAM10 and ADAM17 Proteins in Interleukin-6 (IL-6) Trans-signaling and Novel Role of ADAM10 in Inducible IL-6 Receptor SheddingJournal of Biological Chemistry, 2011
- Migration of growth factor-stimulated epithelial and endothelial cells depends on EGFR transactivation by ADAM17Nature Communications, 2011
- Critical role of the disintegrin metalloprotease ADAM17 for intestinal inflammation and regeneration in miceJournal of Experimental Medicine, 2010
- Chemotherapy-Induced Activation of ADAM-17: A Novel Mechanism of Drug Resistance in Colorectal CancerClinical Cancer Research, 2010
- Molecular mechanisms of drug resistanceThe Journal of Pathology, 2005